As mentioned previously, ACE2 is the binding site of COVID‐19 and in CKD patients, the kidney expresses ACE2 in the proximal tubules' brush border apical membrane that could help the virus enter and infect the glomerular endothelial cells.40 This evidence concerns the gene ACE2 and chronic kidney disease.